Literature DB >> 35914096

Relationships among Clinical Factors and Patient-reported Outcome Measures in Adults with Convergence Insufficiency.

Ingryd J Lorenzana, David A Leske1, Sarah R Hatt1, Trevano W Dean2, Erin C Jenewein3, Linda R Dagi4, Casey J Beal5, Yi Pang6, Dashaini V Retnasothie7, Christina A Esposito8, S A Erzurum9, Amy E Aldrich10, Eric R Crouch11, Zhuokai Li2, Raymond T Kraker2, Jonathan M Holmes12, Susan A Cotter7.   

Abstract

SIGNIFICANCE: When exploring relationships among clinical measures and patient-reported outcome measures in adults with convergence insufficiency, worse symptoms (Convergence Insufficiency Symptom Survey [CISS] score) seemed to be correlated with worse reading function domain score (Adult Strabismus-20 quality-of-life questionnaire). After treatment, improved symptoms were associated with improved reading function quality of life.
PURPOSE: This study aimed to explore relationships between clinical measures and patient-reported outcome measures in adults undergoing treatment for symptomatic convergence insufficiency.
METHODS: In a prospective multicenter observational study, we evaluated adults with symptomatic convergence insufficiency (i.e., clinical measures of near exodeviation, receded near point of convergence, reduced near positive fusional vergence; CISS score ≥21). Fifty-seven participants treated with vision therapy/exercises (n = 35) or base-in prism (n = 22) were analyzed. Spearman correlation coefficients ( R ) were used to assess associations among the three clinical measures and patient-reported outcome measures (CISS, Diplopia Questionnaire, four Adult Strabismus-20 quality-of-life domains) before treatment (baseline) and after 10 weeks and 1 year. Associations were interpreted to be present when the lower limit of the 95% confidence interval (CI) was moderate to strong ( R ≥ 0.4).
RESULTS: Among multiple exploratory analyses, the only moderate to strong baseline correlation was between worse CISS and worse Adult Strabismus-20 reading function scores ( R = 0.62; 95% CI, 0.43 to 0.76). Regarding change in measures with treatment, the only moderate to strong correlations were between improved CISS and improved Adult Strabismus-20 reading function scores for prism at 10 weeks ( R = 0.78; 95% CI, 0.52 to 0.91) and 1 year ( R = 0.85; 95% CI, 0.65 to 0.94) and for vision therapy/exercises at 1 year ( R = 0.78; 95% CI, 0.57 to 0.89).
CONCLUSIONS: In exploratory analyses, we found positive correlations between CISS symptom scores and reading function quality-of-life scores. The absence of correlations between symptoms and individual clinical measures is consistent with clinical experience that, in convergence insufficiency, symptoms and clinical findings can be discordant.
Copyright © 2022 American Academy of Optometry.

Entities:  

Mesh:

Year:  2022        PMID: 35914096      PMCID: PMC9463113          DOI: 10.1097/OPX.0000000000001929

Source DB:  PubMed          Journal:  Optom Vis Sci        ISSN: 1040-5488            Impact factor:   2.106


  24 in total

1.  Evaluation of the Adult Strabismus-20 (AS-20) questionnaire using Rasch analysis.

Authors:  David A Leske; Sarah R Hatt; Laura Liebermann; Jonathan M Holmes
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-05-04       Impact factor: 4.799

2.  Convergence Insufficiency in the Geriatric Population.

Authors:  Hassan Hashemi; Payam Nabovati; Abbasali Yekta; Mohamadreza Aghamirsalim; Shokoofeh Rafati; Hadi Ostadimoghaddam; Hassan Razmjoo; Mehdi Khabazkhoob
Journal:  Optom Vis Sci       Date:  2021-06-01       Impact factor: 1.973

3.  Linking clinical variables with health-related quality of life. A conceptual model of patient outcomes.

Authors:  I B Wilson; P D Cleary
Journal:  JAMA       Date:  1995-01-04       Impact factor: 56.272

4.  The lack of association between signs and symptoms in patients with dry eye disease.

Authors:  Kelly K Nichols; Jason J Nichols; G Lynn Mitchell
Journal:  Cornea       Date:  2004-11       Impact factor: 2.651

5.  Weak association between subjective symptoms or and objective testing for dry eyes and dry mouth: results from a population based study.

Authors:  E M Hay; E Thomas; B Pal; A Hajeer; H Chambers; A J Silman
Journal:  Ann Rheum Dis       Date:  1998-01       Impact factor: 19.103

6.  Quantifying diplopia with a questionnaire.

Authors:  Jonathan M Holmes; Laura Liebermann; Sarah R Hatt; Stephen J Smith; David A Leske
Journal:  Ophthalmology       Date:  2013-03-24       Impact factor: 12.079

7.  Validity and reliability of the revised convergence insufficiency symptom survey in adults.

Authors:  Michael W Rouse; Eric J Borsting; G Lynn Mitchell; Mitchell Scheiman; Susan A Cotter; Jeffrey Cooper; Marjean T Kulp; Richard London; Janice Wensveen
Journal:  Ophthalmic Physiol Opt       Date:  2004-09       Impact factor: 3.117

8.  Plasmapheresis therapy in rheumatoid arthritis. A controlled, double-blind, crossover trial.

Authors:  I L Dwosh; A R Giles; P M Ford; J L Pater; T P Anastassiades
Journal:  N Engl J Med       Date:  1983-05-12       Impact factor: 91.245

9.  Test-retest reliability of the revised diplopia questionnaire.

Authors:  Sasha A Mansukhani; Sarah R Hatt; David A Leske; Jonathan M Holmes
Journal:  J AAPOS       Date:  2019-10-23       Impact factor: 1.220

10.  Convergence Insufficiency Neuro-mechanism in Adult Population Study Randomized Clinical Trial: Clinical Outcome Results.

Authors:  Tara L Alvarez; Mitchell Scheiman; Elio M Santos; Chang Yaramothu; John Vito d'Antonio-Bertagnolli
Journal:  Optom Vis Sci       Date:  2020-12       Impact factor: 2.106

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.